139 related articles for article (PubMed ID: 17886097)
1. PTEN expression in renal cell carcinoma and oncocytoma and prognosis.
Hager M; Haufe H; Kemmerling R; Mikuz G; Kolbitsch C; Moser PL
Pathology; 2007 Oct; 39(5):482-5. PubMed ID: 17886097
[TBL] [Abstract][Full Text] [Related]
2. Loss of tumor suppressor protein PTEN during renal carcinogenesis.
Brenner W; Färber G; Herget T; Lehr HA; Hengstler JG; Thüroff JW
Int J Cancer; 2002 May; 99(1):53-7. PubMed ID: 11948491
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic and prognostic utility of claudin expression in renal cell neoplasms.
Lechpammer M; Resnick MB; Sabo E; Yakirevich E; Greaves WO; Sciandra KT; Tavares R; Noble LC; DeLellis RA; Wang LJ
Mod Pathol; 2008 Nov; 21(11):1320-9. PubMed ID: 18587324
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma.
Zhu C; Wei J; Tian X; Li Y; Li X
Int J Clin Exp Pathol; 2015; 8(10):12668-77. PubMed ID: 26722456
[TBL] [Abstract][Full Text] [Related]
5. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
6. Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma.
Amend B; Hennenlotter J; Scharpf M; Kruck S; Kuehs U; Senger E; Merseburger AS; Kuczyk MA; Sievert KD; Stenzl A; Bedke J
World J Urol; 2012 Jun; 30(3):353-9. PubMed ID: 21822918
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
8. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin expression in renal cell carcinoma and oncocytoma.
Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F
APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675
[TBL] [Abstract][Full Text] [Related]
11. [Non-metastatic clear cell renal carcinoma: prognostic significance of morphometric and biomolecular factors].
Iurin AG
Vopr Onkol; 2009; 55(2):177-82. PubMed ID: 19514371
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
[TBL] [Abstract][Full Text] [Related]
13. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin expression in normal kidney tissue and renal carcinomas.
Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
[TBL] [Abstract][Full Text] [Related]
15. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?
Horstmann M; Geiger LM; Vogel U; Schmid H; Hennenlotter J; Kuehs U; Merseburger AS; Kruck S; Stenzl A; Bedke J
World J Urol; 2012 Aug; 30(4):525-31. PubMed ID: 21928123
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the KIT/stem cell factor axis in renal tumours.
Horstmann M; Hennenlotter J; Geiger LM; Vogel U; Schmid H; Kuehs U; Stenzl A; Bedke J
Anticancer Res; 2012 Oct; 32(10):4339-45. PubMed ID: 23060556
[TBL] [Abstract][Full Text] [Related]
17. PTEN expression and mutation in colorectal carcinomas.
Li XH; Zheng HC; Takahashi H; Masuda S; Yang XH; Takano Y
Oncol Rep; 2009 Oct; 22(4):757-64. PubMed ID: 19724853
[TBL] [Abstract][Full Text] [Related]
18. Expression of S-100 protein in renal cell neoplasms.
Lin F; Yang W; Betten M; Teh BT; Yang XJ;
Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
[TBL] [Abstract][Full Text] [Related]
19. Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Patton KT; Tretiakova MS; Yao JL; Papavero V; Huo L; Adley BP; Wu G; Huang J; Pins MR; Teh BT; Yang XJ
Am J Surg Pathol; 2004 Aug; 28(8):1045-50. PubMed ID: 15252311
[TBL] [Abstract][Full Text] [Related]
20. Localized non-conventional renal cell carcinoma: prediction of clinical outcome according to histology.
Kim SH; Yang HK; Moon KC; Lee ES
Int J Urol; 2014 Apr; 21(4):359-64. PubMed ID: 24224568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
